March 2026

Rextovy

naloxone hydrochloride

Amphastar Pharmaceuticals Inc

Spray, metered (nasal) · NDA 208969

Last listed protection ended
March 7, 2026

The FDA listed 1 exclusivity for Rextovy, and this is the day the last one ended. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Ended
    New product exclusivity
    FDA code NP